Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect mixed opinions, with some posters emphasizing that the study confirms prior doubts about the effectiveness of screening, using words like 'yet to be proven' and 'doesn't work,' which indicates skepticism. Others highlight regional differences, such as the impact on Malaysia's screening policies, showing how the publication influences policy debates and perceptions of screening's value, though without deeply engaging in methodological critiques.
Most discussions express skepticism or neutrality regarding the findings, with some agreeing with the idea that screening doesn't significantly reduce mortality, while others challenge or question the conclusions.
The discussions show mild curiosity, mainly focusing on the implications of the study rather than deep analysis, indicating moderate interest.
Posts appear to mainly acknowledge the findings without extensive debate or detailed commentary, reflecting neutral or passive engagement.
The conversations suggest that the article influences opinions about prostate cancer screening policies, especially in contexts like Malaysia, where practices differ, hinting at some impact on clinical decisions or public health considerations.
@Kenrickng1 @ProfAdeeba @nazrazak @teng_ong @EChrisDee However in #malaysia where PSA screening is not common, promoting PSA screening will save lives. The arguments based on the PLCO trail against PSA screening is not valid in a country with poor PSA screening penetration like Msia unlike the USA https://t.co/4lNf3NKJcM
@djc795 @instrumenthull @metrics52 And in a time of low-cost nudge-y effectiveness trials being used for causal inference (and hence shrinking intervention adherence) that benefit is becoming ever more important, but it's still quite secondary. Example paper - https://t.co/labQZMPG2D
@LyndaJane8 @RichelTheo @quay_dr https://t.co/SkFnzB2t9t https://t.co/fjWvPIQJsX https://t.co/dPciYm1vte https://t.co/GkkKl8suQf.
@_YoungCR7 Prostate screening doesn't work. https://t.co/EtVqj8FdtU
授業では、PLCOの論文の方だけcontaminationが52%と強調されてたのは、さすがにちょっと議論を誘導したんだろうなぁと思いました笑 https://t.co/BgnOBs4QaE
@SimonMDLord @oscdebosc @ProstateUK Yet to be proven https://t.co/GrltR6orEy
Whats the truth about prostate cancer treatments. There are many options including surgery, radiation, and focal therapies, but current evidence does not conclusively show they save many lives. The risk of complications…
Prostate cancer awareness campaigns often rely on ineffective tests. PSA blood tests and digital rectal exams have high false positive rates and limited reliability, failing to significantly reduce mortality. This video…
Whats the truth about the PSA test? The PSA test is highly unreliable with a high false positive rate and no proven mortality benefit. Most prostate cancers are outlived, and screening may cause more harm than good.
Prostate cancer screening is highly unreliable, with PSA levels often misleading. High false positive rates and inability to distinguish aggressive cancers question its effectiveness in saving lives.
Prostate health refers to the wellbeing of the prostate gland, a crucial organ in male reproductive and urinary health. Prostate cancer awareness programs aim to promote screenings and support, but recent studies…
Men's Health Month in June aims to raise awareness of preventable health issues, promote early detection, and encourage healthy lifestyles. It also includes prostate cancer awareness, which focuses on early screening…
@LyndaJane8 @RichelTheo @quay_dr https://t.co/SkFnzB2t9t https://t.co/fjWvPIQJsX https://t.co/dPciYm1vte https://t.co/GkkKl8suQf.
@lualopes_12 @Minguebson @timao_chico @luizpaulor https://t.co/QDMXCDO0h9
@djc795 @instrumenthull @metrics52 And in a time of low-cost nudge-y effectiveness trials being used for causal inference (and hence shrinking intervention adherence) that benefit is becoming ever more important, but it's still quite secondary. Example paper - https://t.co/labQZMPG2D
@SimonMDLord @oscdebosc @ProstateUK Yet to be proven https://t.co/GrltR6orEy
Comorbidity and mortality results from a randomized prostate cancer screening trial https://t.co/YzpNIUYHO6
授業では、PLCOの論文の方だけcontaminationが52%と強調されてたのは、さすがにちょっと議論を誘導したんだろうなぁと思いました笑 https://t.co/BgnOBs4QaE
@Kenrickng1 @ProfAdeeba @nazrazak @teng_ong @EChrisDee However in #malaysia where PSA screening is not common, promoting PSA screening will save lives. The arguments based on the PLCO trail against PSA screening is not valid in a country with poor PSA screening penetration like Msia unlike the USA https://t.co/4lNf3NKJcM
@_YoungCR7 Prostate screening doesn't work. https://t.co/EtVqj8FdtU